InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
56,854.89
(
-2.48%
)
Post# of 252501
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

caravon

Send PM Follow Ignore
Followers 13
Posts 1058
Boards Moderated 0
Alias Born 02/21/2007

caravon

Re: caravon post# 149797

Tuesday, 10/02/2012 10:21:56 AM

Tuesday, October 02, 2012 10:21:56 AM

Post# of 252501
One more thing. Somehow the results were known to some traders for awhile.

Prior to stopping the trial, ARQL has shared the data with FDA.

It is a $64,000 question, why didn't ARQL test pts for c-Met+ but just collected the samples?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up